Oligodendrocytes (OLs) are the primary targets in the autoimmune disease multiple sclerosis (MS). Cell receptors belonging to the tumor necrosis factor receptor (TNF-R) superfamily, such as TNF receptors and fas, are implicated in signaling the injury response of OLs. The p75 neurotrophin receptor (p75 NTR ), another member of the TNF-R superfamily, has been reported to mediate nerve growth factor (NGF)-induced apoptosis in some neural systems. To address the potential relationship between p75
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Key words: p75 NTR ; oligodendrocytes; human; trkA; NGF; apoptosis; multiple sclerosis; JNK; NF-B Oligodendrocytes (OL s) and their myelin membranes are the primary sites of tissue injury in multiple sclerosis (MS), a chronic autoimmune disease of the human adult C NS (for review, see Raine, 1990) . The extent of oligodendrocyte loss varies early in the disease, but in the later progressive phase of the disease, OL loss is a constant feature Raine, 1994 ). The precise basis for the selective injury of OL s remains to be clearly defined. C andidate cell-mediated immune effector responses include direct effector-target cell interactions or soluble factors derived from lymphocytes or glial cells.
Target cell receptors belonging to the tumor necrosis factor receptor (TN F-R) superfamily are implicated in signaling the injury response of OL s (Selmaj et al., 1991; Ozawa et al., 1994; D'Souza et al., 1995 D'Souza et al., , 1996 . OL s express TN F receptors in situ (Dopp et al., 1997) , and TN F-␣, which is detectable within MS lesions (Selmaj et al., 1991) , induces apoptosis of human adult OL s in vitro (D'Souza et al., 1995) . Human OL s also express fas, both in intact brain and in culture (D'Souza et al., 1996; Bonetti and Raine, 1997) , and fas ligand can be detected on glial cells, microglia, and astrocytes (D'Souza et al., 1996 (D'Souza et al., , 1998 Dowling et al., 1996; Bonetti and Raine, 1997) and on lymphocytes in MS lesions (D'Souza et al., 1996) . Human OL s in vitro undergo cell lysis without evidence of nuclear fragmentation in response to ligation of fas with either fas ligand or with cross-linking antibody (D'Souza et al., 1996) .
The precise mechanisms by which TN F and fas receptors mediate death within postmitotic OL s remain unclear, but a conserved intracellular region termed the "death domain" is required for each of these receptors to interact with the downstream signaling elements that are responsible for mediating apoptosis in other cellular systems (for review, see Baker and Reddy, 1996) . The p75 neurotrophin receptor (p75 N TR ), also a member of the TN F-R superfamily, contains a death domain sequence in its cytoplasmic region, and the presence of this motif has f ueled speculation that this neurotrophin receptor may play a role in mediating apoptosis in vivo (C arter and Lewin, 1997) . The neurotrophins [consisting of nerve growth factor (NGF), brain-derived neurotrophic factor (BDN F), neurotrophin-3 (N T-3), and neurotrophin-4 (N T-4)] are typically considered in terms of their survival-promoting effects that are mediated by neurotrophin-dependent activation of the tyrosine kinase receptors trkA, trkB, and trkC (for review, see Barbacid, 1994) . p75 N TR was initially found to f unction as a coreceptor for the trk receptors (Barker and Shooter, 1994; Hantzopoulos et al., 1994; Mahadeo et al., 1994; Verdi et al., 1994) , but recent data indicate that p75 N TR is also capable of autonomous signaling via neurotrophin-dependent activation of sphingomyelinase activity and nuclear factor (N F) B transcriptional complexes (Dobrowsky et al., 1994; . p75 N TR -mediated signaling has been implicated in the apoptosis of developing retinal cells (Frade et al., 1996) as well as in the apoptosis of neonatal rat OL s that express p75 N TR but that lack trkA (C asaccia-Bonnefil et al., 1996) . An effect of p75 N TR on OL apoptosis accompanied with increased levels of jun kinase (JN K) activity was observed on neonatal rat OL s cells that were induced to differentiate into mature OL s in vitro and maintained in minimal media, but no effect was seen on the immature precursor cells,. A separate report indicates that neonatal rodent OL s grown under more typical growth conditions express both trkA and p75 N TR and that NGF produces a survival effect rather than apoptosis (Cohen et al., 1996) .
The observations that NGF levels are elevated in the CSF of MS patients (Laudiero et al., 1992) and that MS lesions contain both apoptotic OL s (Raine and Scheinberg, 1988; Ozawa et al., 1994; Dowling et al., 1996) and immature OL s with elevated p75 N TR expression (Dowling et al., 1997) raise the possibility that p75 N TR may play a role in the pathogenesis of MS. To address the potential relationship between p75 N TR signaling and OL injury, we cultured adult human OL s under a variety of conditions and assayed them for p75 N TR and trkA expression, for NGF-mediated apoptosis, for NGF-mediated JN K activation, and for NGF-mediated N F-B nuclear translocation. We have found that cultured adult human OL s express p75 N TR and not trkA, and yet, under conditions in which TN F-␣ results in readily detectable apoptosis and JN K activation, NGF treatment did not result in significant OL apoptosis or JN K activation, although it did induce nuclear translocation of N F-B.
MATERIALS AND METHODS
Primar y culture preparation. Human brain tissue was obtained from patients undergoing partial temporal lobe resection for intractable epilepsy. A total of 21 such biopsies were used for this study. The glial cell isolation procedure was as described previously (Yong and Antel, 1992) . Briefly, brain tissue was subjected to enzymatic dissociation with trypsin (0.25%; GI BC O) and DNase I (25 g /ml; Boehringer Mannheim, Indianapolis, I N) for 30 min at 37°C and to mechanical dissociation by passage through a 132 m nylon mesh (Industrial Fabrics Corporation, Minneapolis, M N). Mixed glial cells consisting of ϳ70% OL s, 25% microglia, and 5% astrocytes were obtained by separation on a 30% Percoll (Pharmacia, Dorval, Québec, C anada) gradient (15,000 rpm at 4°C for 30 min). To enrich for OL s, we suspended the mixed-cell population in Eagle's minimal essential medium (M EM) supplemented with 5% fetal calf serum (FC S), 2.5 U/ml penicillin, 2.5 g /ml streptomycin, 2 mM glutamine, and 0.1% glucose (all from GI BC O) and left the culture overnight in 25 cm 2 uncoated Falcon tissue culture flasks (V W R Scientific Products) in a humid atmosphere at 37°C and 5% C O 2 . The less adherent OL s were removed by gentle shaking. The remaining adherent cells in the Falcon tissue culture flasks, consisting of ϳ95% microglia and 5% astrocytes, were allowed to develop in M EM with 5% FC S for 2 d. The enriched microglial preparation was then trypsinized (0.25%) and plated onto uncoated 9-mm-in-diameter Aclar coverslips (Seung K , University of British Columbia) or 16-well chamber slides (Nunc, Naperville, IL) for immunocytochemistry.
The OLs were plated onto poly-L-lysine-(10 g/ml; Sigma, St. Louis, MO) coated 9-mm-in-diameter Aclar coverslips for immunostaining, onto 16-well tissue culture chamber slides for subsequent immunostaining and cell death assays, or onto 60 mm Petri dishes (VWR Scientific Products) for JNK assays and for reverse transcriptase (RT)-PCR. OLs were initially cultured in MEM with 5% FCS at a density of 5 ϫ 10 4 cells/coverslip or microwell and 1 ϫ 10 6 cells/ml in the Petri dishes for 7 d. The cells were then washed with serum-free media and cultured under a series of conditions that would permit comparison with previous studies conducted using rodent OLs. Culture conditions used were DMEM/F12 (1:1) supplemented with 50 g/ml transferrin, 20 nM progesterone, 50 M putrescine, 30 nM selenium, 50 g/ml insulin, 0.3% glucose, 15 mM HEPES, 6 mM glutamine, 2.5 U/ml penicillin, and 2.5 g/ml streptomycin for 7 d; DMEM/ F12 (1:1) with PDGF-AA (20 ng/ml) and b-FGF (20 ng/ml) for 4 d and then transferal to DMEM/F12 without PDGF-AA or b-FGF for 5 d; and serum-free MEM (SF-MEM) for 7 d.
For cell death and JN K assays involving NGF (Collaborative Biomedical Products), TN F-␣ (Genzyme, Boston, M A), and C2-ceramide (Molecular Probes, Eugene, OR) treatments and for N F-B assays using NGF (10 or 100 ng /ml), TN F-␣ (1000 units/ml), and BDN F and N T-3 (100 ng /ml each; both supplied by Regeneron Pharmaceuticals), cells were washed with serum-free media and incubated in SF-M EM or DM EM / F12 (1:1) containing 0.1% bovine serum albumin (DM EB) and supplemented with the above effector molecules as indicated in the figure legends. NGF-dependent neurite outgrowth from pheochromocytoma (PC12) cells was performed using 10 and 100 ng /ml NGF to ensure that the NGF used in all experiments was bioactive (data not shown).
Because pure cultures of adult astrocytes could not be obtained, fetal human astrocytes were used as an alternative for immunocytochemical studies of p75 NTR expression. These were prepared from human fetal CNS tissue obtained at 12-16 weeks of gestation following Medical Research of Canada guidelines. The tissues were mechanically dissociated with scalpel blades and then treated with trypsin (0.25%) and DNase (50 g/ml) at 37°C for 45 min. Dissociated tissue was passed through a 130 m mesh, washed twice in PBS, and the cells, consisting of astroglia, neurons, and sparse microglia, were plated directly onto poly-L-lysine-coated 75 cm 2 Falcon tissue culture flasks in MEM with 5% FCS. After confluence, cultures were split using 0.25% trypsin. Populations of proliferating fetal astrocytes were obtained after three to four passages and plated onto uncoated 9 mm Aclar coverslips or 16-well chamber slides.
Immunoc ytochemistr y. OL s were identified by staining live cells with undiluted supernatant of the O1 hybridoma (gift from Dr. W. Yong, C algary, C anada) for 1 hr at room temperature (RT) followed by three washes in PBS and biotinylated-goat anti-mouse IgG (1:100; C altag, South San Francisco, CA) for 1 hr. After three rinses in PBS, cells were incubated with C y3-conjugated Streptavidin (1:1000; Jackson ImmunoResearch, West Grove, PA) for 15 min at RT. After rinsing again with PBS, coverslips were mounted with gelvatol. The cells were also identified as mature OL s by immunostaining methanol -acetone (1:1)-fixed cells with anti-myelin basic protein (M BP) monoclonal antibody (mAb) (Boehringer Mannheim) (data not shown). Microglia were identified using anti-CD68 mAb (1:150; 1 hr at RT; Dako, C arpenteria, CA), and permeabilized fetal astrocytes were identified using rabbit anti-glial fibrillary acidic protein (GFAP; Dako). For p75 N TR staining, anti-human p75 N TR (Boehringer Mannheim) was used at a dilution of 1:4000 for 1 hr at RT followed by biotinylated-goat anti-mouse IgG and C y 3-conjugated Streptavidin. To detect nuclear translocation of N F-B, we fixed OL s with 4% paraformaldehyde for 20 min at RT and followed with acetone -methanol (1:1) at Ϫ20°C for 10 min. They were then stained with a rabbit polyclonal antibody specific for the p65 subunit of N F-B (1:100; Santa Cruz Biotechnology, Tebu, France) for 1 hr at RT, followed by biotinylated-goat anti-rabbit IgG (1:100; C altag) for 30 min and Cy 3-conjugated Streptavidin (1:1000) for 15 min at RT. For nuclear DNA staining, Hoechst 33258 (1:1000; Molecular Probes) was used on the same cells. After rinsing with PBS, coverslips were mounted with gelvatol. All slides were examined under a Reichert 2 Poly var Leica epifluorescent microscope.
RT-PCR anal ysis. Total RNA was isolated from cultured OL s grown in the different culture conditions described above, using the one-step guanidinium isothiocynate procedure (Chomczinski and Sacchi, 1987) . Total RNA (2.5 g) was used for first-strand cDNA synthesis using SuperScript II RNase H-reverse transcriptase (GI BC O BRL) in 20 l reactions containing 20 mM Tris-HC l, pH 8.4, 0.5 mM deoxynucleotides, 50 mM KC l, 2.5 mM MgC l 2 , 10 mM dithiothreitol, and 50 ng of random hexamers (GI BC O BRL). Five microliters of the resulting cDNA reaction mixture were then used for nested PCR analysis. The initial PCR was performed for 35 cycles at 94°C ϫ 40 sec, 52°C ϫ 60 sec, and 72°C ϫ 90 sec, and the second PCR was performed using 2.5 l of the first reaction mixture for 25 cycles at 94°C ϫ 40 sec, 52°C ϫ 60 sec, and 72°C ϫ 90 sec. Products were analyzed on Tris-borate EDTA (TBE) acrylamide gels stained with ethidium bromide. PCR primers used for the first p75 N TR PCR were p75 N TR -1 (C TC ACA CCG GGG ATG TG) and p75 N TR -2 (GTG GGC C TT GTG GCC TAC), and the nested primers for the second were p75 N TR -3 (TGT GGC C TA CAT AGC C TT C) and p75 N TR -4 (ATG TGG CAG TGG AC T CAC T). For trkA PCR, the initial PCR used primers trkA-1 (ATG AGA CCA GC T TCA TC) and trkA-2 (GC T GTG C TG GCG CCA GA), and the nested primers for the second were trkA-3 (AA CAA CGG CAA C TA CAC) and trkA-4 (C TT GTT TC T CCG TCC AC). The expected final product sizes from cDNA are 476 base pairs for p75 N TR and 279 base pairs for trkA; each of the primer sets span exon and intron boundaries, and genomic fragments are larger than the cDNA sizes indicated above.
Cell death assay: T UNEL staining. After exposure to putative injury mediators, cell cultures in 16-well chamber slides were washed with PBS, fixed with acetone -methanol (1:1) for 15 min at Ϫ20°C, and then rehydrated with PBS for 30 min at RT. C ells were then incubated with 50 l of nick end-labeling solution containing TdT (9.5 units/ml; Promega, Madison, W I) and biotinylated dUTP (10 nmol per ml; Boehringer Mannheim) in terminal transferase (TdT) 5ϫ buffer [500 mM cacodylate buffer, pH 6.8, 5 mM CoCl 2 , and 0.5 mM DTT (Promega)] for 1 hr at 37°C. The reaction was terminated by adding 10 mM Tris-HC l, pH 6.8, for 5 min at RT. After blocking for 5 min with HHG (1% H EPES, 2% horse serum, and 10% goat serum in HBSS; all from GI BC O), the cells were incubated with Streptavidin-FI TC (1:50; 30 min at 37°C; Boehringer Mannheim). To identif y cell nuclei, we stained cells simultaneously with propidium iodide (PI; 10 g /ml; 10 min incubation). Slides were washed in PBS and mounted for counting. Each experiment was conducted on cells derived from at least three different brain specimens. For each experiment, all treatments were performed in replicate (three or four) wells, and 200 -400 cell nuclei per well were counted using a Reichert Poly var 2 Leica epifluorescent microscope.
JNK assay. C ells grown in each of the culture conditions described above were washed in DM EM containing 0.1% BSA and then treated with putative injury mediators (NGF at 100 ng /ml, TN F-␣ at 10 ng /ml, and C2-ceramide at 25 M) for the times indicated in the figure legends. In vitro kinase assays with whole-cell lysates were performed as described in Westwick and Brenner (1995) using Sepharose-conjugated glutathione transferase (GST)-jun (1-223) as substrate. Briefly, 15 g of cell lysate was incubated for 2 hr at 4°C with the Sepharose-coupled substrate. After extensive washes, in vitro kinase assays were performed at 30°C for 20 min. Sepharose-associated phosphorylated substrate was resuspended in sample dissociation buffer and run on 12% SDS-PAGE. Gels were fixed and stained with Coomassie blue to confirm equal loading of GST-jun substrate and then exposed and quantitated on PhosphorImager cassettes (Storm; Molecular Dynamics, Sunny vale, CA).
Data anal ysis. For TdT-mediated d-uridine triphosphate (UTP)-biotin nick-end labeling (TUN EL) assays, the total number of data points were derived as the sum of replicate wells (three or four) from at least three separate experiments. Data collected from the TUN EL assays were analyzed for significance by the ordinary ANOVA test with T ukeyKramer post tests if the p value was Ͻ 0.05. For the JN K assay, significance was assessed using Student's t test.
RESULTS

Expression of p75 NTR but not trk A on adult human OLs
The morphological features of neural cells used in this study are illustrated in Figure 1, A, D , and G. Purity of the OLs in enriched cultures was estimated at 85-90% during the 2-3 week culture period. Contaminating cells included astrocytes and fibroblasts. OLs cultured in medium with b-FGF/PDGF-AA showed numerous processes. OLs grown in the different culture conditions (OLs in MEM with 5% FCS for 7 d then DMEM/F12 plus PDGF-AA/ b-FGF, serum-free MEM, or DMEM/F12 only) were all O1 positive (Fig. 1 B) . P75
NTR expression was observed on cell bodies and processes of OLs (Fig. 1C ) under all three culture conditions. The absence of nonspecific immunoreactivity was verified by performing the immunocytochemistry protocol without primary antibody and by replacing primary antibody with isotypic control antibody. Contaminating cells with morphological characteristics of astrocytes or fibroblasts did not express p75
NTR
. No p75 NTR expression could be detected on adult human microglia or fetal astrocytes in culture (Fig. 1 I, F, respectively) .
When the RT-PCR was performed on OL RNA using specific primers for p75 N TR and trkA, p75 N TR transcripts were detected in OLs from all three culture conditions (Fig. 2) , consistent with the immunocytochemical data. Transcripts for trkA could not be detected in OLs from any of the conditions. Transcripts 2Ј, 3Ј-cyclic nucleotide phosphodiesterase (CNPase), an OL-specific protein, were visualized (data not shown). Samples run without reverse transcriptase showed no contaminating bands. 
NGF does not cause significant apoptosis of OLs in different culture conditions
OL s in the different culture conditions described above were treated with 10 or 100 ng /ml of NGF for durations varying from 24 to 96 hr. TUN EL staining showed no significant apoptosis of the OL s in any of the three culture conditions with NGF at 10 ng/ml or 100 ng /ml at 24 hr (Fig. 3A) . No increase in apoptosis was observed at any of the time points up to 96 hr. In contrast, TNF-␣ induced significant apoptosis of the OL s (20 Ϯ 2%; p Ͻ 0.01) at 96 hr; Fig. 3B ).
NGF treatment of OLs does not lead to significant JNK activation
JN K activity measured with a solid-phase kinase assay was not significantly increased when OL s in the different culture conditions were exposed to 100 ng /ml NGF at time points up to 3 hr (Fig. 4 A, B) . However, under identical conditions, both TNF-␣ (10 ng /ml) and C2-ceramide (25 M) were potent inducers of JN K (Fig. 4 A-C) .
NGF induces nuclear translocation of NF-B
Nuclear translocation of the p65 subunit of NF-B in response to 10 or 100 ng/ml NGF was detected by immunocytochemistry in significant numbers (26 -47%) of OLs under all three culture conditions ( Fig. 5C,D ; Table 1 ) as compared with untreated (control) cultures (8 -12%) (Fig. 5 A, B ; Table 1 ) and those treated with BDNF (7-11%) or NT-3 (7-8%) ( Table 1 ). This effect was observed 3 hr after NGF treatment and was maintained for at least 6 hr. TNF-␣ induced strong nuclear staining at 30 min (data not shown).
DISCUSSION
In this study we show that OLs derived from human adult CNS express p75 N TR but not trkA under any of the culture conditions we have examined. In this regard, the adult human OLs differ from neonatal rat-derived OLs, because maintenance of ratderived cells in b-FGF and PDGF-AA results in expression of trkA, which likely mediates a survival response by NGF (Cohen et al., 1996) . The reasons for this difference in trkA expression is 
Each treatment [NGF 10 and 100 ng/ml; BDNF (100 ng/ml); NT-3 (100 ng/ml) for 5 hr] was evaluated in replicate wells for each culture condition (DMEM / F12, DMEM/F12 with PDGF-AA / b-FGF, or serum-free MEM) on OLs derived from two different brain specimens (n ϭ 4). A total of 75-100 cells were counted in each well. Data are presented as percent cells showing nuclear translocation Ϯ SEM.
unknown but could reflect a species-specific difference in gene expression as is seen in the expression of the CD59 receptor, a complement inhibitory protein, on human but not rodent OLs (Wing et al., 1992; Piddlesden and Morgan, 1993) . It could also reflect the fact that the rat OL s used in previous studies were derived from neonatal animals, whereas the human OLs used in our studies have been postmitotic for a period of many years. In contrast, p75 N TR expression was detected in human OLs under all three culture conditions.
Our previous results have shown that TN F treatment of adult human OL s results in cellular apoptosis (D'Souza et al., 1995) , indicating that a TN F-dependent apoptotic cascade is functional within these cells. In this study, we have compared the effects of TN F and NGF in our standard conditions as well as under the minimal culture conditions in which NGF treatment results in apoptosis of neonatal rat OL s. Treatment of these OLs with varying concentrations of NGF over a range of time periods resulted in no significant increase in the numbers of TUNELpositive OL s, whereas significant injury was observed using TNF.
Several previous studies have examined the expression of NGF receptors and the effects of NGF on OL s, with considerable discord between the various results. Cohen et al. (1996) have found that neonatal rat-derived OL s maintained in b-FGF and PDGF-AA express both p75 N TR and trkA, and NGF promotes the survival of these cells. NGF-mediated proliferation and process extension have been reported for porcine OL s (Althaus et al., 1992) . Using minimal media to maintain neonatal rat-derived immature OL s, C asaccia-Bonnefil et al. (1996) found that rat OL s express p75 N TR but not trkA and that these cells underwent apoptosis in response to NGF. These differing effects of NGF might be explained if activation of trkA results in a dominant proliferation or survival signal that overrides an apoptotic signal derived from p75 N TR . However, our experiments show that human OL s do not express trkA under the culture conditions used either by Cohen et al. (1996 ) or C asaccia-Bonnefil et al. (1996 but, nonetheless, fail to undergo NGF-mediated apoptosis and JN K activation under conditions in which activation of JNK and apoptosis do occur in response to TN F. This difference in responsiveness in the adult human OL s suggests that the signaling properties of p75 N TR show greater cell-type and developmental variability than do those of the apoptotic TN F-R1 and Fas receptors. Reasons for this are unclear but may include differential expression of appropriate p75 N TR signaling partners that remain unidentified.
Recently, p75
N TR -mediated signaling events, such as activation of N F-B transcriptional complex (C arter et al., 1996) and of the sphingomyelin -ceramide pathway (Dobrowsky et al., 1994) , have been identified, and both of these signaling events are consistent with a role for p75 N TR in mediating injury responses within the CNS. However, activation of N F-B in several cell types blocks apoptotic cell death to a variety of insults, including TNF-␣ (Beg and Baltimore, 1996; Liu et al., 1996; Van Antwerp et al., 1996) . Diverse f unctions other than apoptosis have been attributed to autonomous p75 N TR signaling in non-neuronal cells (Herrmann et al., 1993; Anton et al., 1994) . The nuclear translocation of NF-B by NGF in human OL s may indicate a role for NF-B in preventing apoptosis, although its precise f unction remains to be determined.
Mature OL s within the C NS seem to express little, if any, p75 N TR under normal conditions (Yan and Johnson, 1988; Heuer et al., 1990; Yamamoto et al., 1993) . Substantial amounts of p75 N TR were observed on apparently immature OL s in MS tissue (Dowling et al., 1997) . Furthermore, rats with experimental allergic encephalomyelitis, the animal model of MS, also have increased p75 N TR and NGF protein in their brains (De Simone et al., 1996) . Rather than causing toxicity, NGF prevents autoimmune demyelination in marmosets (Diaz et al., 1997) . ␤-Interferon, the approved therapy for MS, induces NGF production by astrocytes (Boutros et al., 1998) . NGF and other neurotrophins continue to be considered for use as therapies in CNS neuronodegenerative disorders, emphasizing the need to define their effects on non-neuronal cells as a consequence of the therapy.
